Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer

TORONTO, Aug. 21, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the appointment of Tricia Symmes as the Company’s Chief Commercial Officer, effective August 27, 2020. Symmes brings over 20 years of experience as a senior executive in the pharmaceutical, consumer packaged goods, and cannabis industries.Continue reading “Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer”

Aleafia Health Announces Second Quarter 2020 Results

“Our significant increase in medical cannabis sales and patient growth, coupled with much needed Cannabis 2.0 formats and dried flower products will see us continue to capture market in both the medical and adult-use markets.” CEO Geoffrey Benic Highlights $57.0M cash, cash equivalents and freely tradeable marketable securities $3.0 million positive adjusted EBITDA 44% increaseContinue reading “Aleafia Health Announces Second Quarter 2020 Results”

Aleafia Health to Commence Cultivation in Entire 160,000 sq. ft. Niagara Greenhouse Facility

“This is an incredibly important breakthrough for Aleafia Health.” Aleafia Health Inc. (TSX: AH, OTC: ALEAF) will now commence operations in the entirety of its 160,000 sq. ft. Niagara Facility. On March 13, 2020, the Company secured its initial cultivation licence authorizing operations in 70,000 sq. ft. of the Niagara Facility. The Company may nowContinue reading “Aleafia Health to Commence Cultivation in Entire 160,000 sq. ft. Niagara Greenhouse Facility”